RGBPD Stock Price, News & Analysis
Company Description
RGBPD (OTC: RGBPD) is a publicly traded biotechnology company in the Healthcare sector. The company has a market capitalization of $6.8M.
RGBPD stock has declined 7.1% over the past year.
This page provides a comprehensive overview of RGBPD stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
RGBPD (RGBPD) stock. Over the past 12 months, the stock has lost 7.1%. At a market capitalization of $6.8M, RGBPD is classified as a micro-cap stock with approximately 3.4M shares outstanding.
Latest News
RGBPD has 2 recent news articles. Of the recent coverage, 2 articles coincided with positive price movement and 0 with negative movement. Key topics include conferences. View all RGBPD news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
RGBPD Company Profile & Sector Positioning
RGBPD (RGBPD) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing RGBPD often look at related companies in the same sector, including Aim Immunotech (AIM), (ADXSD), Nucana (NCNA), Pharmacyte Biotech Inc (PMCB), and Polydex Pharmaceuticals Ltd (POLXF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate RGBPD's relative position within its industry.